Skin Cancer

Start 2018 Right: Plan for Cancer Screening and Save Lives! (01-5-2018)

Screening guidelines should initiate conversations with your healthcare team.  Charles H Weaver MD, Editor CancerConnect CancerConnect News: The goal of cancer screening is to find disease at early stages in people who are otherwise asymptomatic—before... Continue Reading

Skin Cancer Prevention Tips from the Skin Cancer Foundation (05-17-2017)

The development of skin cancer is certainly a risk for any individual, but particularly for those of us who spend time in the outdoors. As summer approaches it’s important to keep in mind that by taking certain steps to protect yourself from the sun,... Continue Reading

Check It Out: May is Skin Cancer Awareness Month (05-1-2017)

Skin cancer is the most commonly diagnosed cancer in the United States. Although the majority of skin cancers fall under basal cell and squamous cell carcinomas (number of cases estimated to be around 5 million), most deaths are a result of melanoma which... Continue Reading

FDA Approves Bavencio as First Treatment for Merkel Cell Cancer (03-31-2017)

The U.S. Food and Drug Administration today granted accelerated approval to Bavencio (avelumab) for the treatment of adults and pediatric patients 12 years and older with metastatic Merkel cell carcinoma (MCC), including those who have not received prior... Continue Reading

Epacadostat Plus Keytruda® Appears Effective in Melanoma (10-11-2016)

The treatment combination consisting of epacadostat plus Keytruda® (pembrolizumab) appears effective in the treatment of advanced melanoma. Melanoma is a type of skin cancer that often starts in the form of a mole. If detected and treatable with surgery,... Continue Reading

Promising Activity of Pembrolizumab in Merkel Cell Carcinoma (06-14-2016)

Treatment of 26 patients with advanced previously untreated Merkel cell carcinoma with Keytruda® (pembrolizumab) every three weeks resulted in an overall response rate of 56% suggesting this novel therapy could represent a new treatment option for these... Continue Reading

National "Check Yourself to Protect Yourself ALL YEAR" Campaign Highlights Need for Year-Round Skin Cancer Prevention (11-12-2015)

Although one in five Americans will get skin cancer in their lifetimes, 65 percent of people of color don’t believe they are at risk and face lower survival rates as a result. To change these odds, the cancer organization Patients Rising will use... Continue Reading

Patients with Multiple Squamous Cell Carcinomas Should be Frequently Monitored (10-21-2015)

Patients with multiple sites of cutaneous squamous cell carcinoma (a type of skin cancer) have a significantly increased risk of developing a recurrence or spread to their lymph nodes, warranting frequent follow-up visits to their dermatologist. These... Continue Reading

Food and Drug Administration approves Odomzo for treatment of basal cell carcinoma (08-13-2015)

The U. S. Food and Drug Administration approved Odomzo® (sonidegib, formerly LDE225) for the treatment of patients with locally advanced basal cell carcinoma (laBCC) that has recurred following surgery or radiation therapy, or those who are not candidates... Continue Reading

New Treatment Options Emerging For Advanced Basal Cell Carcinoma (12-3-2014)

Basal cell carcinoma is the most commonly diagnosed type of skin cancer. Most cases can be treated with surgery or other types of local treatment and are not life threatening. In the most severe cases, the cancer may be very large, may invade structures... Continue Reading

Next Page »